Pfizer is seeking a Senior Director, Team Lead to build the US commercial foundation for prifetrastat (PF-07248144), a first-in-class KAT6 inhibitor in Phase 3 for HR+/HER2- advanced breast cancer following prior CDK4/6 inhibitor therapy. The role owns US launch preparation, connects the strategy to Pfizer’s broader breast cancer franchise, and leads a team of up to 3–4 marketers at Director and Senior Manager levels, including a dedicated launch lead. The position reports to the VP, US Breast Cancer Franchise Lead. The leader will develop the launch strategy and pre-launch P&L, prepare the market and customers, shape access and patient-support plans, and coordinate launch readiness across commercial and cross-functional teams. The work includes addressing the fragmented post-CDK4/6 treatment landscape, biomarker-testing readiness, tolerability and dose management, and customer value. The role also maps the patient journey across first-line and post-CDK4/6 treatment, aligns field plans with Sales and KAD leadership, and uses customer insights, analytics, and innovative approaches—including AI—to evolve the go-to-market model. This is a hybrid position based in New York, NY, or Collegeville, PA, with 2–3 days per week onsite and domestic travel of up to 25% as needed. The role may also require international travel for congresses, sales meetings, and customer interactions. The listed annual base salary range is $214,900–$358,100, with eligibility for a performance bonus and a share-based long-term incentive program.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior